Cargando…
CpG-Based Nanovaccines for Cancer Immunotherapy
Cancer has been a serious health hazard to the people all over the world with its high incidence and horrible mortality. In recent years, tumor vaccines in immunotherapy have become a hotspot in cancer therapy due to their many practical advantages and good therapeutic potentials. Among the various...
Autores principales: | Chen, Wenqiang, Jiang, Mingxia, Yu, Wenjing, Xu, Zhiwei, Liu, Xinyue, Jia, Qingmiao, Guan, Xiuwen, Zhang, Weifen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352601/ https://www.ncbi.nlm.nih.gov/pubmed/34385817 http://dx.doi.org/10.2147/IJN.S317626 |
Ejemplares similares
-
Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy
por: Jiang, Mingxia, et al.
Publicado: (2021) -
Enhancement of Immune Response of Bioconjugate Nanovaccine by Loading of CpG through Click Chemistry
por: Mo, Mengting, et al.
Publicado: (2023) -
The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018) -
Lymph Node-Targeting Nanovaccine through Antigen-CpG Self-Assembly Potentiates Cytotoxic T Cell Activation
por: Xi, Xiaobo, et al.
Publicado: (2018) -
Antibody targeted CpG for the immunotherapy of solid tumors
por: Epstein, Alan L, et al.
Publicado: (2015)